Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
FTSE 100 movers: IAG flies higher after results; GSK in the black
(Sharecast News) - London's FTSE 100 was down 1.3% at 8,178.75 in afternoon trade on Friday. IAG flew higher after the BA and Iberia owner said it would start paying dividends again, posted a rise in first-half profits and abandoned its pursuit of Air Europa.
Russ Mould, investment director at AJ Bell, said: "Against a backdrop of airlines slashing prices to fill planes and negative investor sentiment towards the sector, International Consolidated Airlines has issued a remarkably upbeat set of results.
"Strong travel demand over the past few years has enabled the airline to pay down debt and get its finances in order after a traumatic pandemic. The balance sheet is now deemed strong enough to warrant recommencing dividends, something that investors will welcome with open arms.
"Paying dividends also signals a big step forward for the company and effectively draws a line under previous fears about its financial strength. In essence, recommencing the dividend means the narrative can shift to how the business is growing, not simply how it is repairing previous damage.
"Walking away from a proposed takeover of Air Europa also shows the company has discipline and isn't prepared to spend a long time fighting antitrust regulators to get the deal over the line. Management has clearly decided its time is better spent elsewhere and to just move on. Investors often like companies that take decisive action."
GSK was in the black as it said the US Food and Drug Administration has approved its Jemperli treatment in combination with chemotherapy and then use on its own for adult patients with primary advanced or recurrent endometrial cancer.
FTSE 100 - Risers
International Consolidated Airlines Group SA (CDI) (IAG) 169.55p 5.97% GSK (GSK) 1,582.50p 3.70% Haleon (HLN) 369.50p 3.21% National Grid (NG.) 1,000.00p 2.04% AstraZeneca (AZN) 12,740.00p 1.82% Unilever (ULVR) 4,858.00p 1.59% United Utilities Group (UU.) 1,048.00p 1.45% Fresnillo (FRES) 599.00p 1.27% Reckitt Benckiser Group (RKT) 4,149.00p 1.24% Severn Trent (SVT) 2,621.00p 1.24%
FTSE 100 - Fallers
Melrose Industries (MRO) 485.80p -5.67% Intermediate Capital Group (ICG) 2,018.00p -5.35% Pershing Square Holdings Ltd NPV (PSH) 3,600.00p -5.16% Ashtead Group (AHT) 5,194.00p -4.84% Vistry Group (VTY) 1,309.00p -4.52% Scottish Mortgage Inv Trust (SMT) 813.60p -4.46% Barclays (BARC) 213.25p -4.33% Mondi (MNDI) 1,475.50p -4.28% 3i Group (III) 2,969.00p -3.98% Diploma (DPLM) 4,206.00p -3.97%
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.